Recall Register

Drug recall: Loxapine Capsules USP, 5mg, 100 count bottle, Rx only Manufactured By: Watson Laboratories Inc., Corona, CA 92880 NDC…

Class III FDA enforcement event 62383. Recall start date: . Status in the FDA record: Terminated. Termination date: .

Reason for recall, in the words of FDA

Labeling: Incorrect or Missing Package Insert: An outdated version of a patient outsert was used when packaged.

Class III, in the words of FDA

a situation in which use of or exposure to a violative product is not likely to cause adverse health consequences

Watson Laboratories Inc started this drug recall on 17 Apr 2012. The firm address in the FDA record is in Corona, CA. FDA put the recall in Class III. FDA event 62383 has 5 product records. The first FDA enforcement report date is 11 Jul 2012. The record gives the status Terminated, with the termination date 18 Mar 2013.

It is important to note that most of the time recall classifications are determined after the recalling firm provides all of the information needed to determine the risk posed to public health. The classification and posting in the FDA Enforcement Report should not be seen as an expansion or change to a firm’s voluntary public warning.

FDA publishes these words. Source: FDA, Enforcement Reports, Important Note, read on . openFDA export of .

Distribution

In the words of FDA.

Nationwide.

Recalling firm

Watson Laboratories Inc, Corona, CA.

Recalling firm: The firm that the FDA record names for a recall.

FDA records how the recall started: Voluntary: Firm initiated.

Products

5 product records in the event.

FDA event 62383: product records
Recall numberProductQuantityClassStatusReport date
D-1399-2012Loxapine Capsules USP, 5mg, 100 count bottle, Rx only Manufactured By: Watson Laboratories Inc., Corona, CA 92880 NDC # 00591-0369-01.8254 bottlesClass IIITerminated11 Jul 2012
D-1400-2012Loxapine Capsules USP, 10mg, 100 count bottle, Rx only, Manufactured By: Watson Laboratories Inc., Corona, CA 92880 Rx only. NDC # 0591-0370-01106,323 bottlesClass IIITerminated11 Jul 2012
D-1401-2012Loxapine Capsules USP, 25mg, 100 count bottle, Rx only, Manufactured By: Watson Laboratories Inc., Corona, CA 92880 NDC # 0591-0371-0121,572 bottlesClass IIITerminated11 Jul 2012
D-1402-2012Loxapine Capsules USP, 50mg, 100 count bottle, Rx only Manufactured By: Watson Laboratories Inc., Corona, CA 92880 NDC # 0591-0372-0118,902 bottlesClass IIITerminated11 Jul 2012
D-1403-2012Loxitane Capsules, Loxapine Succinate Capsules, 10mg base, 100 count bottle, Rx only, Watson Laboratories Inc., Corona, CA 92880 NDC # 52544-495-017,262 bottlesClass IIITerminated11 Jul 2012

openFDA, about the status: FDA does not update the status of a recall after the recall has been classified according to its level of hazard. As such, the status of a recall (open, completed, or terminated) will remain unchanged after published in the Enforcement Reports. Source: openFDA, Drug Recall Enforcement Reports, Disclaimer.

Enforcement report: The FDA publication that lists recalls. It has one record for each product of a recall.

Enforcement event: All the product records that have one FDA event number. This site shows one event on one page.

Class III: The lowest of the three FDA recall classes.

The event in context

Drug events that started in 2012
209
Share of these events in Class III
28%
Product records in this event
5Median of the firm: 1
Events of the firm on the register
13

Other events of the firm

Other FDA enforcement events of Watson Laboratories Inc
InitiatedProduct (first record)TypeClassRecords
15 Jan 2014Hydrocodone Bitartrate and Acetaminophen Tablets USP, CIII, 10 mg/ 660 mg, 100 count bottles, Rx only. Manufactured by WDrugClass II1
23 Dec 2013Carisoprodol Tablets, USP, CIV, 350 mg, 500 count bottle, Rx only. Manufactured by Watson Pharma Private Ltd, Verna, SalDrugClass II1
23 Sep 2013Next Choice" One Dose Emergency Contraceptive (Levonorgestrel Tablet), 1.5 mg, 1 Tablet/Blister Card (NDC 52544-287-54),DrugClass II1
13 Sep 2013Oxycodone and Acetaminophen Tablets, USP 10 mg/650 mg, CII, 100 Count Bottles, Rx Only, Manufactured by: Watson LaboratoDrugClass II1
30 Aug 2013Hydrocodone Bitartrate and Acetaminophen Tablets, 7.5 mg/650 mg Tablets, 500 Count Bottle, Manufactured by: Watson LaborDrugClass III1
19 Jul 2013Oxycodone and Acetaminophen Capsules, USP 5mg/500 mg, packaged in a)100-count bottle (NDC 0591-0737-01), b) 500-count boDrugClass III1
13 Feb 2013ZARAH Drospirenone/ Ethinyl Estradiol Tablets, 3.0 mg/0.03 mg, Rx only, 3 tablet dispensers, 28 tablets each, Manuf. by:DrugClass II1
8 Feb 2013Meprobamate, Tablets USP, 200 mg, 100 tablets; Rx only; Manufactured By: Watson Laboratories, Inc., Corona, CA 92800 USADrugClass II2
13 Dec 2012Caziant (desogestrel and ethinyl estradiol) Tablets, USP, (Triphasic Regimen), 0.1 mg/0.025 mg, 0.125 mg/0.025 mg, 0.15 DrugClass III1
19 Oct 2012Zovia (ethynodiol diacetate and ethinyl estradiol) Tablets USP, 1 mg/35 mcg, inert tablets, 28-count tablets per dispensDrugClass II5

Watson Laboratories Inc: all 13 events

Official channels

Cite this page

Recall Register. FDA enforcement event 62383. https://recallregister.com/fda/iii/62383/. Source: openFDA enforcement reports. Data through .

Sources

Source
openFDA drug enforcement reports
Licence
CC0 1.0
Export date
28 Sep 2026
Newest FDA report date on the register
23 Sep 2026

FDA has one record for each product. This site puts the records with the same event number on one page. The class of the event is the highest class of its records. How the register is made. Report an error.

Questions

Where was the product distributed?
The FDA record gives this distribution: Nationwide.
What quantity of product is in FDA event 62383?
The event has 5 product records. The first record gives this quantity: 8254 bottles
How did the recall start?
The FDA record says: Voluntary: Firm initiated
How many drug recalls of 2012 have the same class?
28% of the 209 drug events that started in 2012 are in Class III.